Bacterial infections continue to be a leading cause of mortality and morbidity
in blood or bone marrow transplant (BMT) patients. The relative importance of different clinical features (donor type, graft cell source, and conditioning
regimen) on the incidence and timing of post-transplant bacterial infections
is uncertain, but a detailed analysis could better guide prevention and therapy. We retrospectively analyzed the incidence and risk factors for bacterial infection, as well as patterns of antibiotic resistance, in 834 BMT patients at the University of Minnesota from 2005-2010. We found that
donor type has the greatest impact on the incidence of infection in BMT patients out to 100 days post-transplant. Full intensity, myeloablative conditioning, compared to reduced intensity conditioning is also associated with a greater risk of bacteremia, as is later development of acute GVHD. Additionally, BMT patients, compared to the contemporaneous hospital population, develop infections with resistance to many antibiotics used for both prophylaxis and treatment against commonly isolated bacterial
organisms. These findings have important clinical implications regarding the
use and selection of both prophylaxis and empiric antibiotic regimens.
This research was supported by the Undergraduate Research Opportunities Program (UROP).
Clinical Risk Factors for Infection and Antibiotic Resistance in BMT Patients.
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.